Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

002880.SZ

HOLDREMOVE

Shenzhen Weiguang Biological Products Co., Ltd. · Healthcare · China · $845M · Avg Vol: $5M/d

48
StockRank
Q
56
V
38
M
45
P/E (TTM)
21.9x
ROE
9.8%
D/E
0.3x
Dividend %
0.9%
AI CONVICTION THESIS

Shenzhen Weiguang Biological is a domestic Chinese blood products manufacturer. It operates in a highly regulated local market with no exposure to our core global macro themes or CDMO pricing power trends.

COMPANY DESCRIPTION

Shenzhen Weiguang Biological Products Co., Ltd. is a specialized biopharmaceutical company focused on the research, development, and manufacture of human blood products, including albumin, immunoglobulin, and coagulation factors. The company operates under a highly regulated licensing regime in China, which creates extremely high barriers to entry for new competitors. Its competitive moat is sustained by its network of proprietary plasma donation centers and strict quality control standards.

FINANCIAL SUMMARY

Year2022202320242025CAGR
Revenue99M155M178M187M23.8%
EPS0.080.140.170.1628.0%
Shares227M227M227M227M0.0%
Debt81M78M101M124M15.3%
Equity272M298M327M357M9.4%
Op CF177,21159M26M39M503.2%
Inv CF-72M-52M-35M-38M
Fin CF66M-13M12M13M
Loading...
PRICE (1M)-11.7%
3.243.423.603.783.96Apr 30May 26Jun 15
SMA 50SMA 200
Close
$3.35
RSI (14)
21.8
52W High
$4.96
From 52W High
0.7%

SCORE BREAKDOWN

Quality
56
ROIC
10.0%73.6
ROE
9.8%71.5
GP/Assets
13.2%31.9
Op. Margin
19.0%80.9
FCF/Assets
-1.9%44.4
Piotroski
55.8
Int. Cover
14.5x69.7
D/E Ratio
0.33x41.2
Current Ratio
2.36x43.8
Value
38
P/E (TTM)
21.9x52.3
EV/EBITDA
13.4x31.8
P/FCF
N/A
P/B
2.1x53.8
P/S
4.1x47.1
Div Yield
0.9%24.1
Momentum
45
52W High %
68%52.8
RS 6M
-21%53.7
SMA 50/200
0.95x47.2
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
+31%42.0
Q Growth
-29%18.3

FUNDAMENTALS

Market Cap
$845M
P/E (Forward)
16.7x
Gross Margin
38.8%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 002880.SZ are excluded.

TickerCompanyMkt CapStockRankSignal
002880.SZShenzhen Weiguang Biological Products Co., Ltd.(you)$845M48HOLD
688366.SSShanghai Haohai Biological Technology Co., Ltd.$1.1B48HOLD
688293.SSShanghai OPM Biosciences Co., Ltd.$898M42HOLD
600866.SSStar Lake Bioscience Co., Inc.Zhaoqing Guangdong$1.2B46HOLD
688767.SSHangzhou Biotest Biotech Co.,Ltd.$842M39HOLD
003020.SZHefei Lifeon Pharmaceutical Co., Ltd.$557M45HOLD
603229.SSZhejiang Ausun Pharmaceutical Co., Ltd.$1.2B43HOLD
688202.SSShanghai Medicilon Inc.$1.2B53HOLD
688315.SSNovogene Co., Ltd.$870M60HOLD
301333.SZR&G PharmaStudies Co., Ltd.$724M38HOLD

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.1%

Shenzhen Weiguang Biological Products Co., Ltd. (002880.SZ) — Stock Score Summary

Shenzhen Weiguang Biological Products Co., Ltd. (002880.SZ) has a MoatMap StockRank of 48/100 based on Quality (56/100), Value (38/100), and Momentum (45/100) factor scores. The current signal is HOLD. Shenzhen Weiguang Biological is a domestic Chinese blood products manufacturer. It operates in a highly regulated local market with no exposure to our core global macro themes or CDMO pricing power trends.

Shenzhen Weiguang Biological Products Co., Ltd. is a specialized biopharmaceutical company focused on the research, development, and manufacture of human blood products, including albumin, immunoglobulin, and coagulation factors. The company operates under a highly regulated licensing regime in China, which creates extremely high barriers to entry for new competitors. Its competitive moat is sustained by its network of proprietary plasma donation centers and strict quality control standards.

Key Financial Metrics

Price$3.35
Market Cap$845M
P/E (TTM)21.93
P/E (Forward)16.73
Price/Book2.10
Return on Equity9.8%
Return on Invested Capital10.0%
Debt/Equity32.86
Gross Margin38.8%
Operating Margin19.0%
Revenue Growth-1.4%
Dividend Yield0.9%
Free Cash Flow$-2M

Shenzhen Weiguang Biological Products Co., Ltd. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Shenzhen Weiguang Biological Products Co., Ltd.’s (002880.SZ) StockRank?
MoatMap’s StockRank for Shenzhen Weiguang Biological Products Co., Ltd. (002880.SZ) is 48/100, with a Hold signal. It is a composite of Quality (56), Value (38), and Momentum (45) factor ranks across MoatMap’s 19,000+ stock universe.
Does Shenzhen Weiguang Biological Products Co., Ltd. have an economic moat?
Shenzhen Weiguang Biological Products Co., Ltd. (002880.SZ) has a Quality factor score of 56/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Shenzhen Weiguang Biological Products Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Shenzhen Weiguang Biological Products Co., Ltd. (002880.SZ) is Hold, based on a StockRank of 48/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Shenzhen Weiguang Biological Products Co., Ltd. in?
Shenzhen Weiguang Biological Products Co., Ltd. (002880.SZ) operates in the Healthcare sector, specifically the Biotechnology industry (China).